Table 1:
Standard Profile Group (n=120 observations) | Enhanced Profile Group (n=133 observations) | Comparison | |||
---|---|---|---|---|---|
Question | Percent Correct | Percent Incorrect/Unsure | Percent Correct | Percent Incorrect/Unsure | P-value |
1. Identify the number of prescriptions in the patient’s profile | 95.0% | 5% | 96.2% | 3.8% | 0.63 |
2. Identify if there were 4 or more providers for controlled substances used in the past year | 85.8% | 14.2% | 97.0% | 3% | <0.01 |
3. Identify if there were any overlapping opioid and benzodiazepine prescriptions | 87.5% | 12.5% | 94.7% | 5.3% | 0.03 |
4. Identify if there were any overlapping opioid prescriptions | 70.8% | 29.2% | 89.5% | 10.5% | <0.01 |
5. Identify if there were 4 or more pharmacies use for controlled substances in the past year | 81.7% | 18.3% | 43.6% | 56.4% | <0.01 |
6. Identify if there were times when the patient was taking more than 100 morphine milligram equivalents (MME) per day | 25.0% | 75% | 99.2% | 0.8% | 0.02 |
7. Identify if there were any self-pay (cash) prescriptions filled | 89.2% | 10.8% | 93.2% | 6.8% | 0.25 |
8. Identify if there were any times that the patient traveled more than 50 miles from their home address to have a prescription filled | 2.5% | 97.5% | 79.7% | 20.3% | <0.01 |
9. Identify if the patient had any buprenorphine prescriptions | 89.2% | 10.8% | 94.7% | 5.3% | 0.16 |
P values <0.05 are considered statistically significant and are in bold text.